Ursula Ravens Wins Prestigious Schmiedeberg Medal for Cardiac Research

Professor Ursula Ravens has been awarded the Schmiedeberg Medal, the highest honour from the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The award recognises her pioneering work on cardiac arrhythmias, particularly atrial fibrillation. The ceremony took place on March 18, 2026, during the 11th German Pharm-Tox Summit in Düsseldorf. Ursula Ravens made history as the first woman in Germany to hold a chair in pharmacology and toxicology. She studied medicine in both Freiburg and Vienna before building a distinguished career in research. Even after retiring, she continued her work as a visiting professor at the Institute of Experimental Cardiovascular Medicine in Freiburg.

The DGPT highlighted her decades of dedication to research and teaching. Her studies on atrial fibrillation have advanced understanding of heart rhythm disorders, influencing both science and clinical practice. The Schmiedeberg Medal, named after a founding figure in pharmacology, celebrates exceptional contributions to the field. The award ceremony formed part of the Pharm-Tox Summit, a key event for pharmacologists and toxicologists. Ravens' recognition underscores her lasting impact on cardiovascular medicine and education.

The Schmiedeberg Medal adds to Ravens' long list of achievements in pharmacology. Her research on atrial fibrillation remains influential in medical science. The award also acknowledges her role in shaping future generations of scientists through teaching and mentorship.